EFFICACY & SAFETY OF TADALAFIL IN LOWER URINARY TRACT SYMPTOMS DUE TO BENIGN PROSTATIC HYPERPLASIA - A RANDOMISED CLINICAL STUDY

niversity College of Medical Sciences University of Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients aged >= 45 years upto 80 years giving informed consent to participate in the study.
•2. Patients with clinical symptoms of BPH without absolute and or any urgent indication for surgery.
•3. Symptomatic patients with enlarged prostate gland documented with either clinical examination or by ultrasound.
•4. Patients without clinical or investigatory evidence of UTI.
•5. Patients newly diagnosed with BPH .
•6. Patients with diagnosed BPH but not on any medication or stopped medications for the past 2 weeks.
•7. Patients of BPH with IPSS Score >7.

•1. Patients with mental disorders or illness who cannot understand or comply with the study protocol.
•2. Patients of BPH with secondary complications due to BPH (like CRF, hydronephrosis, acute bacterial prostatitis, hematuria).
•3. Patients with LUTS/BOO due to causes other than BPH (neurogenic causes).
•4. Patients with known drug allergy/contraindications to tamsulosin/ tadalafil.
•5. Patients taking nitrates for angina pectoris, CYP3A4 inhibitors (ketoconazole, ritonavir) and CYP3A4 inducers (rifampin).
•6. Patients with previous history of prostate surgery.
•7. Cancer prostate

发起方

niversity College of Medical Sciences University of Delhi